- Home
- STM vs STE Comparison
STM vs STE Comparison
Compare STM & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STM
- STE
- Stock Information
- Founded
- STM 1987
- STE 1985
- Country
- STM Netherlands
- STE United States
- Employees
- STM N/A
- STE N/A
- Industry
- STM Semiconductors
- STE Industrial Specialties
- Sector
- STM Technology
- STE Health Care
- Exchange
- STM Nasdaq
- STE Nasdaq
- Market Cap
- STM 22.3B
- STE 23.9B
- IPO Year
- STM 1994
- STE 1992
- Fundamental
- Price
- STM $32.07
- STE $230.85
- Analyst Decision
- STM Buy
- STE Buy
- Analyst Count
- STM 8
- STE 9
- Target Price
- STM $32.00
- STE $261.00
- AVG Volume (30 Days)
- STM 7.1M
- STE 511.6K
- Earning Date
- STM 07-24-2025
- STE 08-05-2025
- Dividend Yield
- STM 0.98%
- STE 0.98%
- EPS Growth
- STM N/A
- STE 63.01
- EPS
- STM 1.18
- STE 6.21
- Revenue
- STM $12,321,000,000.00
- STE $5,459,515,000.00
- Revenue This Year
- STM N/A
- STE $7.61
- Revenue Next Year
- STM $14.19
- STE $6.04
- P/E Ratio
- STM $26.39
- STE $37.48
- Revenue Growth
- STM N/A
- STE 6.24
- 52 Week Low
- STM $17.25
- STE $200.98
- 52 Week High
- STM $43.32
- STE $252.79
- Technical
- Relative Strength Index (RSI)
- STM 66.69
- STE 35.79
- Support Level
- STM $31.44
- STE $236.73
- Resistance Level
- STM $32.62
- STE $243.08
- Average True Range (ATR)
- STM 0.60
- STE 3.75
- MACD
- STM 0.08
- STE -1.11
- Stochastic Oscillator
- STM 86.75
- STE 5.05
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.